713MO Nivolumab and ipilimumab combination treatment in advanced gynaecological clear cell cancers: Results from the phase II MoST-CIRCUIT trialOliver Klein, Bo Gao, Yoland Antill et al.|Annals of Oncology|2024Cited by 11
282P Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancerOliver Klein, A. Nagrial, Matteo S. Carlino et al.|Annals of Oncology|2024Cited by 3
998MO Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT studyOliver Klein, M.S. Carlino, Bo Gao et al.|Annals of Oncology|2024Cited by 1